Crohn Disease [clinicaltrials_resource:9dfdf232e2fb941e374c4f05f7016639]
clinicaltrials:NCT00038766Study Evaluating rhIL-11 in Active Crohn's Disease [clinicaltrials:NCT00040521]Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease [clinicaltrials:NCT00056355]clinicaltrials:NCT00094458Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn’s Disease [clinicaltrials:NCT00102921]clinicaltrials:NCT00126373Immune Ablation and Stem Cell Support for Crohn's Disease [clinicaltrials:NCT00179842]Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease [clinicaltrials:NCT00206596]clinicaltrials:NCT00206661clinicaltrials:NCT00206674clinicaltrials:NCT00206700clinicaltrials:NCT00206713A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease [clinicaltrials:NCT00207662]A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease [clinicaltrials:NCT00207675]A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease [clinicaltrials:NCT00207766]clinicaltrials:NCT00261976clinicaltrials:NCT00265122An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease [clinicaltrials:NCT00269841]An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease [clinicaltrials:NCT00269854]Early Alimentation Following Colorectal Surgery [clinicaltrials:NCT00290524]clinicaltrials:NCT00295165clinicaltrials:NCT00297193Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 [clinicaltrials:NCT00308438]A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease [clinicaltrials:NCT00317369]Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas [clinicaltrials:NCT00354367]clinicaltrials:NCT00364130Use of FDG PET/CT to Evaluate Crohn Disease [clinicaltrials:NCT00383344]Post-Op Quality of Life After Colorectal Surgery [clinicaltrials:NCT00468455]clinicaltrials:NCT00511329Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas [clinicaltrials:NCT00517296]clinicaltrials:NCT00521950clinicaltrials:NCT00552058A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease [clinicaltrials:NCT00552344]Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease [clinicaltrials:NCT00561548]Stop Infliximab in Patients With Crohn's Disease [clinicaltrials:NCT00571337]Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel [clinicaltrials:NCT00587210]clinicaltrials:NCT00609752An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease [clinicaltrials:NCT00653094]Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED) [clinicaltrials:NCT00705471]Remicade Infusion Management Program [clinicaltrials:NCT00723905]
condition [clinicaltrials_vocabulary:condition]
Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease [clinicaltrials:NCT00004423]Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease [clinicaltrials:NCT00004941]Monoclonal Antibody Treatment of Crohn's Disease [clinicaltrials:NCT00007163]G-CSF to Treat Crohn's Disease [clinicaltrials:NCT00025805]Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease [clinicaltrials:NCT00032786]Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease [clinicaltrials:NCT00032799]Multicenter Trial For Patients With Acute Crohn's Disease [clinicaltrials:NCT00035503]clinicaltrials:NCT00038766Study Evaluating rhIL-11 in Active Crohn's Disease [clinicaltrials:NCT00040521]CP-461 for the Treatment of Crohn's Disease [clinicaltrials:NCT00042055]Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [clinicaltrials:NCT00048113]Alicaforsen (ISIS 2302) in Patients With Active Crohn’s Disease [clinicaltrials:NCT00048295]Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease [clinicaltrials:NCT00055367]clinicaltrials:NCT00055497A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00055523]Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease [clinicaltrials:NCT00055536]Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease [clinicaltrials:NCT00056355]Quality of Life in Pediatric Inflammatory Bowel Disease [clinicaltrials:NCT00061737]Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease [clinicaltrials:NCT00072839]A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease [clinicaltrials:NCT00072943]An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00074542]Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00077779]A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease [clinicaltrials:NCT00078611]STA-5326 in Crohn's Disease Patients [clinicaltrials:NCT00088062]clinicaltrials:NCT00094458clinicaltrials:NCT00098111Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease [clinicaltrials:NCT00101946]Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn’s Disease [clinicaltrials:NCT00102921]Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00105300]An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease [clinicaltrials:NCT00106314]clinicaltrials:NCT00109473Imuran Dosing in Crohn's Disease Study [clinicaltrials:NCT00113503]VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease [clinicaltrials:NCT00114465]Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease [clinicaltrials:NCT00114803]clinicaltrials:NCT00126373clinicaltrials:NCT00130390Vitamin D Treatment for Crohn´s Disease [clinicaltrials:NCT00132184]clinicaltrials:NCT00132899Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease [clinicaltrials:NCT00138840]Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients [clinicaltrials:NCT00138879]
condition browse [clinicaltrials_vocabulary:condition-browse]
Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease [clinicaltrials:NCT00004423]Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease [clinicaltrials:NCT00004941]Monoclonal Antibody Treatment of Crohn's Disease [clinicaltrials:NCT00007163]G-CSF to Treat Crohn's Disease [clinicaltrials:NCT00025805]Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease [clinicaltrials:NCT00032786]Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease [clinicaltrials:NCT00032799]Multicenter Trial For Patients With Acute Crohn's Disease [clinicaltrials:NCT00035503]clinicaltrials:NCT00038766Study Evaluating rhIL-11 in Active Crohn's Disease [clinicaltrials:NCT00040521]CP-461 for the Treatment of Crohn's Disease [clinicaltrials:NCT00042055]Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease [clinicaltrials:NCT00048113]Alicaforsen (ISIS 2302) in Patients With Active Crohn’s Disease [clinicaltrials:NCT00048295]Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease [clinicaltrials:NCT00055367]clinicaltrials:NCT00055497A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00055523]Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease [clinicaltrials:NCT00055536]Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease [clinicaltrials:NCT00056355]Quality of Life in Pediatric Inflammatory Bowel Disease [clinicaltrials:NCT00061737]Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease [clinicaltrials:NCT00072839]A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease [clinicaltrials:NCT00072943]An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00074542]Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00077779]A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease [clinicaltrials:NCT00078611]STA-5326 in Crohn's Disease Patients [clinicaltrials:NCT00088062]clinicaltrials:NCT00094458clinicaltrials:NCT00098111Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease [clinicaltrials:NCT00101946]Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn’s Disease [clinicaltrials:NCT00102921]Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease [clinicaltrials:NCT00105300]An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease [clinicaltrials:NCT00106314]clinicaltrials:NCT00109473Imuran Dosing in Crohn's Disease Study [clinicaltrials:NCT00113503]VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease [clinicaltrials:NCT00114465]Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease [clinicaltrials:NCT00114803]clinicaltrials:NCT00126373clinicaltrials:NCT00130390Vitamin D Treatment for Crohn´s Disease [clinicaltrials:NCT00132184]clinicaltrials:NCT00132899Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease [clinicaltrials:NCT00138840]Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients [clinicaltrials:NCT00138879]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Crohn Disease [clinicaltrials_resource:9dfdf232e2fb941e374c4f05f7016639]
Bio2RDF identifier
9dfdf232e2fb941e374c4f05f7016639
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9dfdf232e2fb941e374c4f05f7016639
identifier
clinicaltrials_resource:9dfdf232e2fb941e374c4f05f7016639
title
Crohn Disease
@en
type
label
Crohn Disease [clinicaltrials_resource:9dfdf232e2fb941e374c4f05f7016639]
@en
Crohn Disease